Impact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE

Takeshi Yoshimoto1,2, Kazunori Toyoda3, Masafumi Ihara1

  • 1Department of Neurology (T. Yoshimoto, M.I.), National Cerebral and Cardiovascular Center, Suita, Japan.

Stroke
|April 20, 2022
PubMed

Insights

Elderly patients with nonvalvular atrial fibrillation and prior stroke/TIA face higher risks of stroke, bleeding, and death. Direct oral anticoagulants reduced hemorrhagic events compared to warfarin in these patients.

Area of Science:

  • Cardiology
  • Geriatrics
  • Pharmacology

Background:

  • Nonvalvular atrial fibrillation (NVAF) is a common condition in the elderly.
  • Stroke and transient ischemic attack (TIA) are significant complications of NVAF.
  • Understanding long-term event incidence in elderly NVAF patients based on stroke history and anticoagulation is crucial.

Purpose of the Study:

  • To determine long-term event incidence in elderly NVAF patients.
  • To compare outcomes between NVAF patients with and without a history of stroke/TIA.
  • To evaluate the safety and efficacy of direct oral anticoagulants (DOACs) versus warfarin in NVAF patients with prior ischemic stroke/TIA.

Main Methods:

  • Prospective, multicenter, observational study of NVAF patients aged ≥75 years.
  • Patients were divided into groups based on history of stroke/TIA.
  • Primary endpoint: stroke/systemic embolism within 2 years. Secondary endpoints: major bleeding and all-cause death within 2 years. Cox models were used for analysis.

Main Results:

  • Over 32,000 patients were analyzed; 22.6% had a history of stroke/TIA.
  • Patients with prior stroke/TIA had higher risks of stroke/systemic embolism, major bleeding, and all-cause death.
  • Among patients with prior ischemic stroke/TIA, DOACs were associated with lower risks of major bleeding, intracranial hemorrhage, and cardiovascular death compared to warfarin.

Conclusions:

  • Elderly NVAF patients with a history of stroke/TIA experience more subsequent ischemic and hemorrhagic events.
  • DOACs demonstrate a favorable safety profile regarding hemorrhagic events in NVAF patients with prior ischemic stroke/TIA compared to warfarin.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
52
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
1.6K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
37
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
34
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
85
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
67